Compile Data Set for Download or QSAR
Report error Found 88 Enz. Inhib. hit(s) with all data for entry = 978
TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM35667([3H]Argipressin tannate | AVP | [3H]Arginine vasop...)
Affinity DataEC50:  40nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301711(US10131692, Compound 43 ([Val4]dDAVP))
Affinity DataEC50:  50nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301678(US10131692, Compound 10)
Affinity DataEC50:  70nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301674(US10131692, Compound 6)
Affinity DataEC50:  80nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301693(US10131692, Compound 25)
Affinity DataEC50:  80nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301699(US10131692, Compound 31)
Affinity DataEC50:  100nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301691(US10131692, Compound 23)
Affinity DataEC50:  100nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301676(US10131692, Compound 8)
Affinity DataEC50:  100nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301701(US10131692, Compound 33)
Affinity DataEC50:  100nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301669(US10131692, Compound 1)
Affinity DataEC50:  100nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301702(US10131692, Compound 34)
Affinity DataEC50:  110nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301708(US10131692, Compound 40)
Affinity DataEC50:  120nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301690(US10131692, Compound 22)
Affinity DataEC50:  140nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301704(US10131692, Compound 36)
Affinity DataEC50:  170nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301681(US10131692, Compound 13)
Affinity DataEC50:  190nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301698(US10131692, Compound 30)
Affinity DataEC50:  190nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301677(US10131692, Compound 9)
Affinity DataEC50:  190nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301684(US10131692, Compound 27 | US10131692, Compound 16)
Affinity DataEC50:  200nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301680(US10131692, Compound 12)
Affinity DataEC50:  210nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301703(US10131692, Compound 35)
Affinity DataEC50:  210nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301673(US10131692, Compound 5)
Affinity DataEC50:  220nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301709(US10131692, Compound 41)
Affinity DataEC50:  220nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM50205308(CHEMBL1429 | (S)-1-((4R,7S,10S,13S,16S)-7-(2-amino...)
Affinity DataEC50:  220nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301686(US10131692, Compound 18)
Affinity DataEC50:  220nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301684(US10131692, Compound 27 | US10131692, Compound 16)
Affinity DataEC50:  230nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301679(US10131692, Compound 11)
Affinity DataEC50:  230nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301689(US10131692, Compound 21)
Affinity DataEC50:  250nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301706(US10131692, Compound 38)
Affinity DataEC50:  260nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301682(US10131692, Compound 14)
Affinity DataEC50:  260nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301688(US10131692, Compound 20)
Affinity DataEC50:  270nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301694(US10131692, Compound 26)
Affinity DataEC50:  270nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301700(US10131692, Compound 32)
Affinity DataEC50:  290nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301671(US10131692, Compound 3)
Affinity DataEC50:  290nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301687(US10131692, Compound 19)
Affinity DataEC50:  290nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301705(US10131692, Compound 37)
Affinity DataEC50:  300nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301707(US10131692, Compound 39)
Affinity DataEC50:  310nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301675(US10131692, Compound 7)
Affinity DataEC50:  310nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301696(US10131692, Compound 28)
Affinity DataEC50:  320nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301672(US10131692, Compound 4)
Affinity DataEC50:  330nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301692(US10131692, Compound 24)
Affinity DataEC50:  350nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301685(US10131692, Compound 17)
Affinity DataEC50:  350nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301697(US10131692, Compound 29)
Affinity DataEC50:  380nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301670(US10131692, Compound 2)
Affinity DataEC50:  390nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V2 receptor(Human)
Ferring

US Patent
LigandPNGBDBM301683(US10131692, Compound 15)
Affinity DataEC50:  450nMAssay Description:Agonist activity of compounds on the human V2 receptor (h V2R) was determined in a transcriptional reporter gene assay by transiently transfecting an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Ferring

US Patent
LigandPNGBDBM35667([3H]Argipressin tannate | AVP | [3H]Arginine vasop...)
Affinity DataEC50:  5.40E+3nMAssay Description:To determine selectivity, compounds were tested in luciferase-based transcriptional reporter gene assays expressing the human V1b receptor (hV1bR). A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Ferring

US Patent
LigandPNGBDBM50205308(CHEMBL1429 | (S)-1-((4R,7S,10S,13S,16S)-7-(2-amino...)
Affinity DataEC50:  6.59E+3nMAssay Description:To determine selectivity, compounds were tested in luciferase-based transcriptional reporter gene assays expressing the human V1b receptor (hV1bR). A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Ferring

US Patent
LigandPNGBDBM301711(US10131692, Compound 43 ([Val4]dDAVP))
Affinity DataEC50:  2.41E+4nMAssay Description:To determine selectivity, compounds were tested in luciferase-based transcriptional reporter gene assays expressing the human V1b receptor (hV1bR). A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Ferring

US Patent
LigandPNGBDBM301702(US10131692, Compound 34)
Affinity DataEC50:  4.02E+4nMAssay Description:To determine selectivity, compounds were tested in luciferase-based transcriptional reporter gene assays expressing the human V1b receptor (hV1bR). A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Ferring

US Patent
LigandPNGBDBM301694(US10131692, Compound 26)
Affinity DataEC50:  4.58E+4nMAssay Description:To determine selectivity, compounds were tested in luciferase-based transcriptional reporter gene assays expressing the human V1b receptor (hV1bR). A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Ferring

US Patent
LigandPNGBDBM301674(US10131692, Compound 6)
Affinity DataEC50:  5.76E+4nMAssay Description:To determine selectivity, compounds were tested in luciferase-based transcriptional reporter gene assays expressing the human V1b receptor (hV1bR). A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: